In vivo purging with rituxan prior to stem cell collection is associated with persistant molecular evidence of T(14;18) that often disappears post transplant in patients with follicular lymphoma. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Buckstein, RJ
  • Imrie, K
  • Spaner, D
  • Bordeleau, Louise
  • Iakhnina, E
  • Pennell, N
  • Coovadia, A
  • Reis, M
  • Hewitt, K
  • Richardson, P
  • Lima, A
  • Robinson, JB
  • Berinstein, NL

publication date

  • November 15, 1999

published in